CytRx Corporation (NASDAQ: CYTR) filed a report with the FDA in response to the Agency's partial clinical hold ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE